163 related articles for article (PubMed ID: 27029063)
21. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
23. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G; Ishikawa H; Tsuji H; Nomiya T; Makishima H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Haruyama Y; Kobashi G; Tsujii H;
Cancer; 2016 Oct; 122(20):3225-3231. PubMed ID: 27351298
[TBL] [Abstract][Full Text] [Related]
24. [What is the level of evidence of new techniques in prostate cancer radiotherapy?].
Khadige M; Peiffert D; Supiot S
Cancer Radiother; 2014 Oct; 18(5-6):501-8. PubMed ID: 25192625
[TBL] [Abstract][Full Text] [Related]
25. Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
Glowa C; Peschke P; Brons S; Neels OC; Kopka K; Debus J; Karger CP
Radiat Oncol; 2017 Nov; 12(1):174. PubMed ID: 29121984
[TBL] [Abstract][Full Text] [Related]
26. [The preliminary report of a registration clinical trial of proton and heavy ion irradiation].
Lu JD; Ye M; Guo Q; Fu JF; Moyers XM; Zhang ST; Mao NY; Kong YS; Hsi X; Shahnazi XY; Zhao JH; Zhang B; Ma JY; Lai YXZ; Zhang W; Ma J; Gao LN; Cai XM; Guan S; Zhang GL; Wu JF; Cheng L; Sheng Z; Ren XM; Zhao J; Sun L; Jiang G
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):52-56. PubMed ID: 29365418
[No Abstract] [Full Text] [Related]
27. Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.
Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
Radiother Oncol; 2014 Oct; 113(1):60-5. PubMed ID: 25287484
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
[TBL] [Abstract][Full Text] [Related]
29. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
30. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
31. Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902).
Wakatsuki M; Kato S; Ohno T; Karasawa K; Ando K; Kiyohara H; Tsujii H; Nakano T; Kamada T; Shozu M;
Gynecol Oncol; 2014 Jan; 132(1):87-92. PubMed ID: 24183732
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.
Akakura K; Tsuji H; Suzuki H; Ichikawa T; Ishikawa H; Okada T; Kamada T; Harada M; Tsujii H; Shimazaki J
Jpn J Clin Oncol; 2014 Apr; 44(4):360-5. PubMed ID: 24585931
[TBL] [Abstract][Full Text] [Related]
33. Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes.
Faria SL; Neto OB; Cury F; Shenouda G; Russel R; Souhami L
Can J Urol; 2016 Apr; 23(2):8209-14. PubMed ID: 27085825
[TBL] [Abstract][Full Text] [Related]
34. Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study.
Ishikawa H; Tsuji H; Kamada T; Yanagi T; Mizoe JE; Kanai T; Morita S; Wakatsuki M; Shimazaki J; Tsujii H;
Radiother Oncol; 2006 Oct; 81(1):57-64. PubMed ID: 16971008
[TBL] [Abstract][Full Text] [Related]
35. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.
Fuentes-Raspall MJ; Caragol I; Alonso C; Ramón y Cajal T; Fisas D; Seoane A; Carvajal N; Bonache S; Díez O; Gutiérrez-Enríquez S
Apoptosis; 2015 Mar; 20(3):371-82. PubMed ID: 25398538
[TBL] [Abstract][Full Text] [Related]
37. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.
Kaver I; Pecht M; Trainin N; Greenstein A; Braf Z
Oncology; 1992; 49(2):108-13. PubMed ID: 1574245
[TBL] [Abstract][Full Text] [Related]
38. Thoracoscopic talc poudrage decreases T-lymphocytes in the peripheral blood.
Froudarakis ME; Papadaki HA; Klimathianaki M; Damianaki A; Pougounias M; Kotsianidis I; Astoul P
Respir Med; 2007 Jun; 101(6):1212-7. PubMed ID: 17182238
[TBL] [Abstract][Full Text] [Related]
39. [Lymphocyte subpopulations in middle ear effusions].
Skotnicka B; Stasiak-Barmuta A; Hassmann-Poznańska E
Otolaryngol Pol; 2002; 56(6):695-700. PubMed ID: 12577484
[TBL] [Abstract][Full Text] [Related]
40. Changes in T-lymphocytes in lung cancer patients after hyperthermic intraperitoneal chemotherapy or radiotherapy.
Yan L; Wu M; Ba N; Shi G; Wang L; Zhang H
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
